RecruitingPhase 3NCT04267848Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])Sponsor: National Cancer Institute (NCI)Akron, OH · Alliance, OH · Beavercreek, OH · +1147 more sites
RecruitingPhase 3NCT06561386A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%Sponsor: Bristol-Myers SquibbCanton, OH · Centerville, OH · Cincinnati, OH · +53 more sites
RecruitingPhase 2NCT05642572Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)Sponsor: SWOG Cancer Research NetworkBelpre, OH · Canton, OH · +451 more sites
RecruitingPhase 2 / Phase 3NCT03851445Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung CancerSponsor: SWOG Cancer Research NetworkAlliance, OH · Athens, OH · Beachwood, OH · +1226 more sites